Are Biotech Stocks Overvalued and in a Bubble?

March 26 -- Clearbridge Investments Health Care Analyst Marshall Gordon discusses the performance of biotech stocks. Bloomberg’s Drew Armstrong also speaks on “Market Makers.”

Full Show: What'd You Miss? (09/20)
54:10 - Guests include: Ohio Governor John Kasich. (Source: Bloomberg)
  • Lasry Says Market Will Take 'Big Hit' Without Tax Reform
  • Full Show: Surveillance (09/19)
  • Full Show: What'd You Miss? (09/19)